Emulate says 'lung chips' to be used to study COVID-19

By The Science Advisory Board staff writers

December 8, 2020 -- Emulate said that the U.S. Army will be using its Alveolus Lung-Chip technology to study the effects of the SARS-CoV-2 virus on human lung tissue.

Specifically, researchers at the U.S. Army Combat Capabilities Development Command (DEVCOM) Chemical Biological Center are using the Lung-Chip technology to observe intracellular interactions and to better understand the role of proteins within lung cells on disease processes, according to the company.

The research is being funded by the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

If you like this content, please share it with a colleague!

Related Reading

Emulate to provide FDA with 'lung chips' to evaluate COVID-19 vaccines
Emulate has entered a cooperative research and development agreement with the U.S. Food and Drug Administration (FDA) to enable multiple studies to evaluate...

Liver-Chip can now determine human-specific toxicities
A group of academic and industry researchers developed new Liver-Chips with four cell types found in the livers of rats, dogs, and humans. The idea was...